|
RSL1D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.765500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.596400E-02 |
| Normal-vs-Stage2 |
2.297600E-01 |
| Normal-vs-Stage3 |
3.909600E-02 |
| Normal-vs-Stage4 |
7.298400E-02 |
| Stage1-vs-Stage2 |
6.924000E-01 |
| Stage1-vs-Stage3 |
7.746800E-01 |
| Stage1-vs-Stage4 |
9.488600E-01 |
| Stage2-vs-Stage3 |
5.795200E-01 |
| Stage2-vs-Stage4 |
7.014400E-01 |
| Stage3-vs-Stage4 |
8.817600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.666200E-02 |
| Normal-vs-AfricanAmerican |
2.903600E-01 |
| Normal-vs-Asian |
4.624000E-02 |
| Caucasian-vs-AfricanAmerican |
8.495600E-01 |
| Caucasian-vs-Asian |
6.324600E-01 |
| AfricanAmerican-vs-Asian |
5.881000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.894300E-02 |
| Normal-vs-Female |
5.616500E-02 |
| Male-vs-Female |
4.953800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.685600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.596200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.239610E-01 |
| Normal-vs-Age(81-100Yrs) |
1.581840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.920000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.517800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.946600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.993600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.928800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.225200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.132200E-01 |
| Classical-VS-Follicular |
2.591500E-02 |
| Classical-VS-Other |
8.105400E-01 |
| Classical-VS-Normal |
1.307770E-01 |
| Tall-VS-Follicular |
2.223200E-01 |
| Tall-VS-Other |
7.934000E-01 |
| Tall-VS-Normal |
2.774800E-01 |
| Follicular-VS-Other |
5.034800E-01 |
| Follicular-VS-Normal |
7.043400E-03 |
| Other-VS-Normal |
9.311200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.386000E-02 |
| Normal-vs-N1 |
1.538660E-03 |
| N0-vs-N1 |
8.694300E-02 |
|
|
